This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Merck Seeks Authorization From US Regulators for Antiviral COVID-19 Treatment
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck and Ridgeback Biotherapeutics, in an undated photograph. Merck/Reuters
Merck and its partner on Oct. 11 announced that they filed an emergency use authorization application with the U.S. Food and Drug Administration (FDA) for their oral antiviral medicine for the treatment of COVID-19.
The pill is meant to combat cases of mild or moderate COVID-19.
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
